Percentage change of DHA+EPA blood cell membrane levels from baseline at week 4. After 4 weeks of treatment, blood cell membrane DHA and EPA levels were significantly increased in all SC411 doses (P < .001) vs baseline; 36 mg/kg, 60 mg/kg, and pooled treatments were also significantly increased vs placebo (P < .01).